Image: Shutterstock
Lilly's weight loss drug Zepbound generates $175M within weeks as Mounjaro sales also soar
Eli Lilly’s weight loss drug Zepbound has pulled in $175.8 million in revenue since its approval in November, the Indianapolis pharma said Tuesday in its …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
